Promethium Advisors,Llc Bristol Myers Squibb CO Transaction History
Promethium Advisors,Llc
- $146 Billion
- Q4 2024
A detailed history of Promethium Advisors,Llc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Promethium Advisors,Llc holds 56,050 shares of BMY stock, worth $3.37 Million. This represents 2.17% of its overall portfolio holdings.
Number of Shares
56,050
Previous 69,550
19.41%
Holding current value
$3.37 Million
Previous $3.6 Billion
11.9%
% of portfolio
2.17%
Previous 2.54%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,764Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.4 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.53 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.77 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.72 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.62 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $128B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...